Study of NGM313 in Obese Participants

NCT03298464 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Obese

Interventions

BIOLOGICAL: NGM313
DRUG: Pioglitazone

Sponsor

NGM Biopharmaceuticals, Inc